Patricia started her career in clinical trial management across neurology and neurosurgery at Mount Sinai and NYU Langone. She has also been on the clinical operations and quality assurance teams at TrialSpark, a healthcare technology startup focused on bringing new treatments to patients.

Following TrialSpark, Patricia became the Director of Operations at Regel Therapeutics, Script Biosciences, and HitchBio. Currently at PhiFund, she continues to support the fund’s portfolio companies while managing fund infrastructure, operations, and investor relations.